Cargando…
'Psoriasis 1' reduces T-lymphocyte-mediated inflammation in patients with psoriasis by inhibiting vitamin D receptor-mediated STAT4 inactivation
Psoriasis is an immune-mediated dermatosis characterized by T-lymphocyte-mediated epidermal hyperplasia, for which there are currently no effective clinical treatments. 'Psoriasis 1' is a Chinese herbal medicine formulation that has been recently used extensively in China for treating pati...
Autores principales: | Gao, Yang, Sun, Wen, Cha, Xushan, Wang, Hailong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447312/ https://www.ncbi.nlm.nih.gov/pubmed/32945358 http://dx.doi.org/10.3892/ijmm.2020.4695 |
Ejemplares similares
-
‘Psoriasis 1’ reduces psoriasis-like skin inflammation by inhibiting the VDR-mediated nuclear NF-κB and STAT signaling pathways
por: Sun, Wen, et al.
Publicado: (2018) -
Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice
por: Jeon, Yoon-Jae, et al.
Publicado: (2017) -
Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis
por: Tao, Tingjun, et al.
Publicado: (2022) -
Mediators of Pruritus in Psoriasis
por: Reich, Adam, et al.
Publicado: (2007) -
TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
por: Sidler, Daniel, et al.
Publicado: (2017)